This page shows the latest Sigma-Tau Pharmaceuticals news and features for those working in and with pharma, biotech and healthcare.
3, 080. Cosmo Technologies/ Salix Pharmaceuticals. Merger (tax inversion). Portfolio of treatments for gastrointestinal disease and disorders. ... 360. Sigma-Tau/ Jazz Pharmaceuticals. Regaining rights. Defibrotide for severe hepatic veno-occlusive
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Lemus was also chief executive officer of Sigma Tau Pharmaceuticals and chief financial officer and executive vice president of MorphoSys, where he took the company public in 1999.
Rare disease specialist Sigma-Tau Pharmaceuticals has appointed Michael Minarich as chief executive officer. ... Prior to joining Sigma-Tau, Micharich was the Pharmacia Corporation's market company president in the Czech Republic and oversaw the merger
More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.
No results were found
Langland, a Publicis Health company, is the only health communications agency that thinks further across Clinical Trial Experience, Medical Strategy...